STOCK TITAN

Enfusion Inc - ENFN STOCK NEWS

Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.

Enfusion, Inc. (symbol: ENFN) is a pioneering provider of cloud-based portfolio management and risk systems, headquartered in Chicago, Illinois. With branch offices in New York, as well as wholly-owned subsidiaries in London and Hong Kong, Enfusion stands at the forefront of delivering innovative solutions to clients within the financial services industry. Their advanced software as a service (SaaS) platform empowers investment managers by unifying mission-critical systems and providing a single dataset for real-time performance, risk calculations, and accounting of complex financial products.

Enfusion's core business revolves around transforming the investment management industry by eliminating technology and information barriers, allowing investment managers to make informed decisions swiftly and efficiently. The company's solutions simplify investment and operational workflows, coalescing data into a single source of truth. This integrated approach helps clients manage over $90 billion in assets across some of the world's largest and most respected hedge funds.

Enfusion's recent achievements highlight its exceptional growth trajectory. The company has expanded its operations significantly, with maximum revenue generation from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa. Their innovative platform is trusted by numerous global clients for its real-time performance and robust risk management capabilities.

Enfusion continues to innovate and refine its offerings. Some of their current projects include enhancing their cloud-based solutions to further streamline investment processes and improve data accuracy. The company also emphasizes strong partnerships and collaboration with other industry leaders to bring the latest technological advancements to their clients.

Financially, Enfusion is on solid footing, experiencing rapid growth and affirming its position as a leader in the investment management software industry. The company's client base spans across the globe, relying on Enfusion's cutting-edge solutions to navigate the complexities of financial management.

Overall, Enfusion, Inc. is a crucial player in the financial services industry, known for its commitment to innovation, client satisfaction, and delivering value through state-of-the-art technology.

Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) has announced the promotion of Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of Sales for EMEA. These promotions underscore Enfusion’s commitment to global expansion and internal talent development. Iris, based in New York, will drive strategic initiatives and has a robust background in strategy, including tenure at Bridgewater Associates and Boston Consulting Group. Lotte will focus on business development across Europe, the Middle East, and Africa, building on her successful track record since joining Enfusion in 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.66%
Tags
none
-
Rhea-AI Summary

Enfusion, Inc. has partnered with Coinbase Global Inc. to integrate systems for seamless cryptocurrency trading, marking Coinbase's first collaboration with an OEMS provider. This connection will enable financial institutions to view and trade crypto alongside traditional assets using Enfusion's platform. Expected to be completed in Q2 2022, this integration aims to meet rising institutional demand for crypto exposure. Enfusion supports diverse asset classes and has established itself as a leader in investment management software.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) has launched significant updates to its mobile app, enhancing its front-to-back-office investment management platform. The app now offers real-time access to portfolio management, compliance monitoring, and secure document sharing for portfolio managers and traders. With over 680 investment managers utilizing their cloud-based services, the app's functionalities include robust order and execution management, enabling seamless trading regardless of physical location. This innovation aligns with industry trends towards increased decentralization and flexibility in asset management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
none
-
Rhea-AI Summary

Enfusion, a cloud-based investment management software provider, has announced the opening of its first office in Sydney, Australia. This expansion aims to meet the growing demand for operational solutions from investment managers in Australia and New Zealand. CEO Thomas Kim highlighted the company's commitment to enhancing service for existing clients and expanding their global presence, having already entered the Asia-Pacific market in 2019. The Sydney office marks their tenth global location, reinforcing Enfusion’s strategy to offer customized SaaS solutions worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
none
-
Rhea-AI Summary

Enfusion (NYSE: ENFN) has announced the appointment of Bronwen Bastone as Chief People Officer and the election of Jan Hauser and Kathleen DeRose to its Board of Directors. Bastone brings over 20 years of experience in human capital management, previously holding senior roles at major financial institutions. DeRose and Hauser will enhance the board's expertise in financial services and fintech. CEO Thomas Kim expressed confidence in the new appointments as Enfusion aims to strengthen its leadership and client service capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.94%
Tags
management
Rhea-AI Summary

Enfusion, a cloud-based investment management software provider, reported a strong third quarter for 2021 with revenue increasing 46.8% year over year to $29.0 million. Key drivers included new client signings and growth from existing clients, with Platform Subscriptions revenue growing 48.4% to $27.1 million. However, income from operations fell to $4.9 million, down from $6.2 million in the prior year, and net income decreased to $3.3 million from $5.6 million. Looking ahead, Enfusion anticipates fourth-quarter revenue between $30.0 and $30.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
-
Rhea-AI Summary

Plate IQ has secured $160 million in Series B funding led by FTV Capital to enhance its AP automation solutions. Under new CEO Barrett Boston, the company aims to expand its VendorPay network across diverse industries. Since March 2020, Plate IQ has onboarded over 8,000 customers and processed more than $2 billion in payments. The platform, noted for its significant impact on the restaurant sector, processes over 50,000 invoices daily, emphasizing its growth potential in the evolving digital payments landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
-
Rhea-AI Summary

Vagaro, a cloud-based business management platform for health and wellness industries, has raised new funding led by FTV Capital, valuing the company at $1 billion. The investment will enhance Vagaro's tools for appointment booking, inventory management, and payroll, supporting international growth in Canada, Australia, and the United Kingdom. The company reported a 105% increase in client sales over the past year and aims to capture a share of the $10.5 billion health and wellness market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.1%
Tags
none
Rhea-AI Summary

Enfusion, a provider of cloud-based investment management solutions, successfully closed its IPO, offering 21,562,500 shares of Class A stock priced at $17.00 per share. This includes the full exercise of underwriters' options to purchase an additional 2,812,500 shares. The offering consisted of 16,839,107 shares sold by Enfusion and 4,723,393 shares by existing stockholders. The IPO proceeds will be utilized to acquire equity interests in its subsidiary and for debt repayment, IPO expenses, and corporate needs. Shares began trading on the NYSE on October 21, 2021 under the symbol ENFN.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.06%
Tags

FAQ

What is the current stock price of Enfusion (ENFN)?

The current stock price of Enfusion (ENFN) is $11.48 as of February 28, 2025.

What is the market cap of Enfusion (ENFN)?

The market cap of Enfusion (ENFN) is approximately 1.1B.

What does Enfusion, Inc. do?

Enfusion, Inc. provides cloud-based portfolio management and risk systems for the financial services industry.

Where is Enfusion headquartered?

Enfusion is headquartered in Chicago, Illinois.

What is Enfusion's core business focus?

Enfusion focuses on transforming the investment management industry by eliminating technology and information barriers.

How much in assets do Enfusion's clients manage?

Enfusion's clients manage over $90 billion in assets.

In which regions does Enfusion generate the most revenue?

Enfusion generates the most revenue from the Americas, followed by Asia Pacific and EMEA regions.

What recent achievements has Enfusion made?

Enfusion has seen exceptional growth and expanded its global operations significantly.

What kind of clients does Enfusion serve?

Enfusion serves global clients, including some of the world’s largest and most respected hedge funds.

How does Enfusion simplify investment and operational workflows?

Enfusion simplifies workflows by unifying mission-critical systems and providing a single dataset for accurate data management.

What are some current projects Enfusion is working on?

Enfusion is working on enhancing cloud-based solutions to streamline investment processes and improve data accuracy.

What is Enfusion's market position?

Enfusion is a leader in the financial services industry, known for its commitment to innovation and client satisfaction.
Enfusion Inc

NYSE:ENFN

ENFN Rankings

ENFN Stock Data

1.07B
88.18M
5.49%
96.34%
0.75%
Software - Application
Services-prepackaged Software
Link
United States
CHICAGO